Natural killer cell immunotherapy in glioblastoma

Glioblastoma (GBM) is one of the most difficult cancers to treat because GBM has the high therapeutic resistance. Recently, immunotherapies for GBM have been used instead of conventional treatments. Among them, Natural killer (NK) cell-based immunotherapy has the potential to treat GBM due to its pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseinalizadeh, Hamed, Habibi Roudkenar, Mehryar, Mohammadi Roushandeh, Amaneh, Kuwahara, Yoshikazu, Tomita, Kazuo, Sato, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616998/
https://www.ncbi.nlm.nih.gov/pubmed/36305981
http://dx.doi.org/10.1007/s12672-022-00567-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616998/
https://www.ncbi.nlm.nih.gov/pubmed/36305981
http://dx.doi.org/10.1007/s12672-022-00567-1

Ejemplares similares